OBJECTIVE
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) have demonstrated cardiorenal benefits in individuals with type 2 diabetes, but safety data in older adults remain limited. We evaluated the real-world safety of SGLT2is compared with dipeptidyl peptidase 4 inhibitors (DPP-4is) among individuals aged ≥75 yea...
Hanin Harbi, Michael Nesrallah, G. Carney et al.· Diabetes Care· 0 citations
Glycated haemoglobin (HbA1c) is used to monitor glycaemic control among patients with type 2 diabetes (T2DM). Glycated haemoglobin represents a 3-month glycaemic average, with the most recent 6 weeks of glycaemia having the greatest influence. Analytical and biological variation introduce imprecision into any single Hb...
Wade Thompson, Tom Perry, Guillaume Grenet et al.· African Journal of Primary H...· 0 citations
Objectives This is a protocol for a Cochrane review (intervention). The objectives are as follows: To determine if lower blood pressure (BP) targets (i.e. ≤ 130/85 mmHg), compared with standard BP targets (i.e. ≤ 140 to 160/90 to 100 mmHg) are associated with reduction in mortality and morbidity in people with elevated...
Doreen Y. Larvie, Anshula Ambasta, Ciprian D. Jauca et al.· Cochrane Database of Systema...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.